Outset Medical (OM)
(Delayed Data from NSDQ)
$13.17 USD
-0.93 (-6.60%)
Updated Aug 6, 2025 04:00 PM ET
After-Market: $17.70 +4.53 (34.40%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth A Momentum F VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
OM 13.17 -0.93(-6.60%)
Will OM be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for OM based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for OM
Outset Medical, Inc. (OM) Reports Q2 Loss, Beats Revenue Estimates
Inspire Medical Systems (INSP) Q2 Earnings and Revenues Surpass Estimates
OM: What are Zacks experts saying now?
Zacks Private Portfolio Services
Strength Seen in Outset Medical (OM): Can Its 15.0% Jump Turn into More Strength?
FMS Stock Likely to Gain on New Optimization Plan FME Reignite
Outset Medical, Inc. (OM) Reports Q1 Loss, Tops Revenue Estimates
Other News for OM
Q2 2025 Outset Medical Inc Earnings Call Transcript
Outset Medical raises 2025 revenue guidance to $122M-$126M while advancing commercial transformation
Outset Medical, Inc. (OM) Q2 2025 Earnings Call Transcript
12 Health Care Stocks Moving In Wednesday's After-Market Session
Outset Medical Non-GAAP EPS of -$0.84 beats by $0.14, revenue of $31.4M beats by $1.99M